BRIEF-Hepalink Pharma's US unit plans to invest in Quest PharmaTech, OncoQuest

Mon Oct 12, 2015 1:31am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Oct 12 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd

* Says its U.S. unit, Hepalink USA Inc, plans to invest C$2 million in Quest PharmaTech Inc by subscribing 25 million new shares

* Says its U.S. unit, Hepalink USA Inc, plans to invest $13 million in OncoQuest Inc by subscribing preference shares

* Says plans to invest $5 million to set up JV in China with OncoQuest Inc

Source text in Chinese: bit.ly/1VN1q0f

Further company coverage:

(Reporting by Hong Kong and Singapore newsrooms)